Sublingual immunotherapy for house dust mite allergy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sublingual immunotherapy for house dust mite allergy, covering 2016-05-19 to 2016-05-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis [Phase 2, Phase 3]